Skip to main content
. 2022 Jun 6;14(6):1208. doi: 10.3390/pharmaceutics14061208

Table 1.

Details of the working solutions used in this work.

NO. Fluid1 Fluid2
F1 10% (w/v) PCL 10% (w/v) CA
F2 10% (w/v) PCL + 6% (v/v) LO 10% (w/v) CA
F3 10% (w/v) PCL 10% (w/v) CA + 4% (w/v) Ag NPs
F4 10% (w/v) PCL + 6% (v/v) LO 10% (w/v) CA + 4% (w/v) Ag NPs